Form 8-K - Current report:
SEC Accession No. 0001564590-17-015996
Filing Date
2017-08-07
Accepted
2017-08-07 16:14:55
Documents
3
Period of Report
2017-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q3 2017 EARNINGS RELEASE 8-K enta-8k_20170807.htm 8-K 25479
2 EX-99.1 enta-ex991_8.htm EX-99.1 315534
3 GRAPHIC g201708071952373462358.jpg GRAPHIC 3526
  Complete submission text file 0001564590-17-015996.txt   347129
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 171011655
SIC: 2834 Pharmaceutical Preparations